Papillary thyroid cancer located in malignant struma ovarii with omentum metastasis: a case report and review of the literature

被引:24
作者
Zhu, Yi [1 ,2 ]
Wang, Chang [3 ]
Zhang, Guo-Nan [1 ]
Shi, Yu [1 ]
Xu, Shi-Qiang [1 ]
Jia, Shi-Jun [4 ]
He, Rong [2 ]
机构
[1] Sichuan Canc Hosp, Dept Gynecol Oncol, 55,Sect 4,South Peoples Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Canc Hosp, Dept Ultrasound, Chengdu 610041, Sichuan, Peoples R China
[3] Chengdu First Peoples Hosp, Dept Obstet & Gynaecol, Chengdu, Sichuan, Peoples R China
[4] Sichuan Canc Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China
关键词
Struma ovarii; Papillary thyroid cancer; Metastases; CARCINOMA; TUMORS; FOCUS;
D O I
10.1186/s12957-016-0776-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The present of malignant transformation in struma ovarii is exceedingly rare. Malignant struma ovarii is usually asymptomatic and infrequently diagnosed preoperatively. Because of its rarity, there is no consensus about diagnosis and management in the literature. Case presentation: A 40-year-old female presented for her obstetric examination with an incidental finding of a pelvic mass. Patient was asymptomatic at presentation. A follow-up ultrasound confirmed the presence of a 3-cm mass in the left adnexa. Patient underwent a cytoreductive surgery (hysterectomy, bilateral salpingectomy and oophorectomy, omentectomy, appendectomy, and pelvic lymphadenectomy). Histopathology revealed a malignant struma ovarii with a focus of papillary thyroid carcinoma and the omentum metastasis. The patient with stage FIGO IIIc received 6 cycles of paclitaxel/carboplatin regimen after surgery. The patient subsequently had a thyroid scan that was normal with normal thyroid function. At a follow-up of 12 months, she is alive, in good clinical condition, and disease-free. Conclusions: Because of the rarity of these tumors and their lack of firm prognostic factors, treatment decisions should be made individually, based on pathologic and clinical parameters.
引用
收藏
页数:4
相关论文
共 21 条
[1]   Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 [J].
Casey, MB ;
Lohse, CM ;
Lloyd, RV .
ENDOCRINE PATHOLOGY, 2003, 14 (01) :55-60
[2]   Metastatic thyroid carcinoma in the presence of struma ovarii [J].
Chan, SW ;
Farrell, KE .
MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (07) :373-374
[3]   SALVAGE CHEMOTHERAPY IN NON-DYSGERMINOMATOUS GERM-CELL TUMORS OF THE OVARY [J].
CULINE, S ;
LHOMME, C ;
FARHAT, F ;
DROZ, JP .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) :1890-1891
[4]   Malignant strurna ovarii:: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy [J].
DeSimone, CP ;
Lele, SM ;
Modesitt, SC .
GYNECOLOGIC ONCOLOGY, 2003, 89 (03) :543-548
[5]   PROLIFERATIVE AND HISTOLOGICALLY MALIGNANT STRUMA OVARII - A CLINICOPATHOLOGICAL STUDY OF 54 CASES [J].
DEVANEY, K ;
SNYDER, R ;
NORRIS, HJ ;
TAVASSOLI, FA .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1993, 12 (04) :333-343
[6]   Malignant struma ovarii with a focus of papillary thyroid cancer: a case report [J].
Doganay, Melike ;
Gungor, Tayfun ;
Cavkaytar, Sabri ;
Sirvan, Levent ;
Mollamahmutoglu, Leyla .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2008, 277 (04) :371-373
[7]   Malignant Struma Ovarii: A Population-Level Analysis of a Large Series of 68 Patients [J].
Goffredo, Paolo ;
Sawka, Anna Mary ;
Pura, John ;
Adam, Mohamed Abdelgadir ;
Roman, Sanziana Alina ;
Sosa, Julie Ann .
THYROID, 2015, 25 (02) :211-215
[8]  
GONZALEZANGULO A, 1963, OBSTET GYNECOL, V21, P567
[9]  
Kabukcuoglu Fevziye, 2002, Pathology and Oncology Research, V8, P145
[10]   Malignant struma ovarii with thyrotoxicosis [J].
Matsuda, K ;
Maehama, T ;
Kanazawa, K .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :575-577